Atrium Health’s Levine Cancer Institute was officially established in 2012, launching the evolution of a multi-site, distributed cancer treatment and research facility.
As one of the leading and most innovative cancer care facilities in the country, the Institute operates within a unique model of care that provides diverse communities access to world class care, close to home. This academic hybrid model combines two important bodies of work – academics and oncology research – with compassionate, community-based cancer care. Levine Cancer Institute has been recognized by US News and World Report as one of the top 50 cancer centers in the country. Learn more here.
In 2019, Atrium Health’s Levine Cancer Institute opened the newest addition to the world- renowned cancer institute: Levine Cancer Institute II (LCI II). LCI II includes nearly 31,000 square feet dedicated to research which will allows for centralized oncology and hematology research as Levine Cancer Institute continued to invest in the development of clinical trials and other research to make it easier and more convenient for patients to access to groundbreaking therapies. Multi-site Phase 1 clinical trials unit provides access to the newest, most innovative therapies and cancer treatment options available.
Levine Cancer Institute cares for over 17,000 patients annually.
Meet the Physician Researchers of Levine Cancer Institute
Physician researchers at Levine Cancer Institute passionately detail how the research partnership with our foundation elevates hope, increases awareness, and creates community.
Strong Partnership: The Paula Takacs Foundation & Levine Cancer Institute
Dr. Derek Raghavan, President of Atrium Health’s Levine Cancer Institute, speaks about the impact the Paula Takacs Foundation for Sarcoma Research’s funding has on their cancer center’s sarcoma research.
Levine Children’s Hospital treats more pediatric patients per day than any other hospital in North Carolina.
Its board-certified physicians in more than 30 areas of pediatric medicine deliver exceptional specialty care that relies on clinical excellence, innovative research and the latest technologies to improve the health of patients. U.S. News & World Report ranks this hospital among the nation’s best hospitals for pediatric cancer care.
Dr. Giselle Sholler, MSc, a pediatric oncologist, is the director of the Isabella Santos Foundation Solid and Rare Tumor Program at Levine Children’s. Prior to her arrival at Levine Children’s, Sholler served as the director of pediatric oncology research and head of the Pediatric Oncology Translational Research Laboratory at Helen DeVos Childrens Hospital in Grand Rapids, Michigan. Dr. Sholler is also the chair, founder, and principal investigator for the nationally renowned Beat Childhood Cancer Research Consortium. Comprised of researchers at 47 hospitals, the consortium and research lab headquarters are located at Atrium Health Levine Children’s Hospital. The pediatric oncology lab works to develop new precision treatments for pediatric cancers and bring early-phase clinical trials to patients, offering the most cutting-edge therapies available.
We are very proud to advance the scientific study of sarcoma globally while working to improve patient outcomes at Levine Cancer Institute and Levine Children’s through these noteworthy projects:
More Details More Details
"The work of the Paula Takacs Foundation is vital to the Levine Cancer Institute's sarcoma research program, enabling us to conduct innovative, scientifically based clinical trials and molecular studies in order to improve the outcomes of treatment. In parallel, we are also able to refine our understanding of the biology and natural history of this set of rare and potentially deadly cancers."
Derek Raghavan MD PhD FACP FRACP FASCO FAAAS
President, Levine Cancer Institute
Chief, Clinical Network Development, Professor of Medicine, Atrium Health
